Alveolar Proteinosis Secondary to M. tuberculosis, in a Patient with Transient CD4 Lymphocytopenia Due to Cryptococcus neoformans Infection : First Case in the Literature
Transient CD4 lymphocytopenia is defined as the transitory presence of CD4+ T lymphocyte fewer than 300 cells/mm3 or less than 20% of T cells without HIV infection. It can occur due to multiple causes; however, it is rare for it to occur due to opportunistic infections. Few cases have been described in the literature where antimicrobial treatment normalizes the CD4 count, being more frequent in Mycobacterium tuberculosis infections. To date, this phenomenon has not been described in Cryptococcus neoformans infections. This would be the first reported case according to our knowledge, of a patient who normalizes CD4 count after antifungal treatment, later developing alveolar proteinosis due to M. Tuberculosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Infectious disease reports - 14(2022), 2 vom: 04. März, Seite 169-175 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Martin Arsanios, Daniel Augusto [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Revised 25.03.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/idr14020021 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338450815 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338450815 | ||
003 | DE-627 | ||
005 | 20231226000714.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/idr14020021 |2 doi | |
028 | 5 | 2 | |a pubmed24n1128.xml |
035 | |a (DE-627)NLM338450815 | ||
035 | |a (NLM)35314651 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Martin Arsanios, Daniel Augusto |e verfasserin |4 aut | |
245 | 1 | 0 | |a Alveolar Proteinosis Secondary to M. tuberculosis, in a Patient with Transient CD4 Lymphocytopenia Due to Cryptococcus neoformans Infection |b First Case in the Literature |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 25.03.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Transient CD4 lymphocytopenia is defined as the transitory presence of CD4+ T lymphocyte fewer than 300 cells/mm3 or less than 20% of T cells without HIV infection. It can occur due to multiple causes; however, it is rare for it to occur due to opportunistic infections. Few cases have been described in the literature where antimicrobial treatment normalizes the CD4 count, being more frequent in Mycobacterium tuberculosis infections. To date, this phenomenon has not been described in Cryptococcus neoformans infections. This would be the first reported case according to our knowledge, of a patient who normalizes CD4 count after antifungal treatment, later developing alveolar proteinosis due to M. Tuberculosis | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Mycobacterium tuberculosis infection | |
650 | 4 | |a cryptococcal infection | |
650 | 4 | |a immune reconstitution | |
650 | 4 | |a interstitial lung disease | |
650 | 4 | |a lymphocytopenia | |
700 | 1 | |a Cubides-Díaz, Diego Alejandro |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Angulo, Natalia |e verfasserin |4 aut | |
700 | 1 | |a Perez-Hernandez, Maria Alejandra |e verfasserin |4 aut | |
700 | 1 | |a Zamora Posada, Marlyn |e verfasserin |4 aut | |
700 | 1 | |a Torres, Mónica Briceño |e verfasserin |4 aut | |
700 | 1 | |a Calderón Vargas, Carlos Mauricio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infectious disease reports |d 2009 |g 14(2022), 2 vom: 04. März, Seite 169-175 |w (DE-627)NLM206505906 |x 2036-7430 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2022 |g number:2 |g day:04 |g month:03 |g pages:169-175 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/idr14020021 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2022 |e 2 |b 04 |c 03 |h 169-175 |